Category: Licensing & Accreditation & Policy

Licensing guidance for all 50 states: Joint Commission and CARF accreditation, CARF 3.7 level of care, license restoration, policy, and audit readiness.

  • Georgia Mental Health Outpatient Licensing: What DBHDD Does and Doesn’t Cover

    Georgia Mental Health Outpatient Licensing: What DBHDD Does and Doesn’t Cover

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Correction, October 2026: an earlier version of this guide said DBHDD licenses outpatient mental health PHP and IOP programs and requires a licensing orientation for them. DBHDD’s own licensure page lists four facility types, and outpatient mental health isn’t one of them. This guide has been rewritten to match. A later check also removed a statement that DATEP applicants must attend an orientation, since DBHDD’s DATEP application packet lists no such step, and softened a claim that a ketamine practice must be physician-owned.

    Georgia Mental Health Outpatient Licensing: The License That Isn’t There

    The Georgia Department of Behavioral Health and Developmental Disabilities (DBHDD) lists four facility types on its licensure page: Adult Residential Mental Health Programs, Community Living Arrangements, Drug Abuse Treatment and Education Programs (DATEPs) and Narcotic Treatment Programs, alongside its separate rules for Crisis Stabilization Units. A private mental health clinic, partial hospitalization program or intensive outpatient program isn’t on that list, and Georgia has no other agency that issues an outpatient mental health facility license. HB 584, which moved DATEP licensing from DCH to DBHDD on January 1, 2026, didn’t create one either.

    So a private-pay therapy practice or a mental health IOP opens in Georgia without a state facility license. That doesn’t make it unregulated. It moves the regulation onto the clinicians, the building and, the moment substance use enters the picture, onto a DATEP license.

    Who actually regulates the program

    Your LPCs, LCSWs and LMFTs hold licenses from the Georgia Composite Board of Professional Counselors, Social Workers and Marriage and Family Therapists, psychologists are licensed by the State Board of Examiners of Psychologists, and psychiatrists and other physicians by the Georgia Composite Medical Board. Those boards set supervision rules for associate-level clinicians, and they’re who investigates a complaint about care. Locally, you still need a business license, a certificate of occupancy and zoning that allows a clinical office.

    Where the line into licensure sits

    Substance use treatment is the trigger. A program that treats alcohol or drug use, including a mental health IOP that adds a co-occurring SUD track, is a DATEP and needs a DBHDD license under the DATEP rules in Chapter 82-10-1. Our Georgia Drug and Alcohol Outpatient Licensing: DATEP Requirements guide covers that application. Programs that want DBHDD public funding go through its provider enrollment and contracting standards, which is a separate process from licensure and outside what this guide covers.

    Realistic timeline

    Without a facility license, the calendar is driven by the lease, the build-out and clinician credentialing with commercial payers, which commonly takes 90 to 150 days per payer. A mental health practice can often open in two to four months. Add a DATEP-licensed SUD component and plan for the longer DATEP timeline instead.

    Ketamine in a Georgia Outpatient Mental Health Practice

    Drawn from DBHDD’s licensure scope, the Georgia Composite Medical Board’s sedation rules and Georgia professional corporation law. No Georgia agency has issued ketamine guidance, so confirm these points before launch.

    With no outpatient mental health license in Georgia, ketamine isn’t something you add to a license. It’s a medical service that lives inside a physician practice, and the practice’s structure is where most of the decisions are.

    Ownership comes first, and it’s a question for health care counsel, because we didn’t find a Georgia statute or Composite Medical Board rule that says who may own a ketamine practice. Many are set up as a professional corporation or an all-physician LLC. Whatever the structure, an NP who orders or monitors sessions can only prescribe the Schedule III to V drugs named in the protocol agreement with a delegating physician, so ketamine has to be written into that agreement. A therapy group or lay investor that wants a stake does it through a management services organization paid a fixed, fair-market fee.

    The open question is sedation. The Composite Medical Board’s Chapter 360-41, Sedation in Physician Offices and Medispas, reaches “any surgery or invasive medical procedure requiring sedation” performed outside a hospital or surgical center. Where it applies, the office has to be equipped and maintained for patient safety, which the rule lets you show through TJC, AAAHC, AAAASF or CMS accreditation. The physician doing the procedure can’t also give the IV sedation or monitor the patient, and someone certified in advanced resuscitation has to be present or immediately available until discharge. Whether a sub-anesthetic IV ketamine infusion counts is not settled anywhere we could find, so put that question to the board before you sign a lease on a suite that can’t support those standards.

    Spravato avoids most of that. The office certifies in the Spravato REMS, the patient self-administers under observation, and staff monitor for at least two hours after each dose, with no IV line involved. If the practice shares space with a DATEP, keep charts and the controlled substance supply separate and get 42 CFR Part 2 consent before records move.

    Frequently Asked Questions

    Does DBHDD license outpatient mental health PHP or IOP programs?

    No. DBHDD licenses Adult Residential Mental Health Programs, Community Living Arrangements, DATEPs and Narcotic Treatment Programs. Georgia has no facility license for a private outpatient mental health program.

    When does a Georgia outpatient program need a DBHDD license?

    When it treats substance use. A program offering alcohol or drug treatment, including a co-occurring track inside a mental health IOP, is a DATEP and needs a DBHDD license, applied for through the GAHLES portal.

    Can a Georgia therapy practice offer ketamine?

    Only with a physician involved. Ketamine is a prescription medical service, so it runs under a physician’s license, and a nurse practitioner can order it only if their protocol agreement with the delegating physician covers it. Who may own the practice is a question for counsel.

    Where This Fits In

    This covers outpatient mental health in Georgia. See Georgia Behavioral Health Licensing for residential programs, DATEPs and the full state picture.

    This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

    Working out whether your Georgia program needs a DATEP license?

    Sources

  • Georgia Mental Health Inpatient Licensing: DBHDD and CSU Requirements

    Georgia Mental Health Inpatient Licensing: DBHDD and CSU Requirements

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Georgia Mental Health Inpatient Licensing: DBHDD, ARMHP, and Crisis Stabilization Units

    Correction (October 2026): an earlier version of this guide said residential mental health licensing was already a DBHDD function before HB 584, that a DBHDD orientation must come before the application, and that residential programs generally need a Certificate of Need. Adult Residential Mental Health Programs moved from DCH to DBHDD on January 1, 2026, neither agency’s application packet lists an orientation, and Georgia’s CON rules for psychiatric beds are written for hospitals.

    Adult Residential Mental Health Programs were licensed by the Department of Community Health until HB 584 moved them to DBHDD on January 1, 2026, so the residential side of mental health changed hands this year just like the substance use side. Crisis Stabilization Units are licensed by DBHDD under their own rules, Chapter 82-3-1.

    Residential treatment centers need DBHDD licensure

    Facilities providing residential treatment services for mental health, Adult Residential Mental Health Programs specifically, need DBHDD licensure. The application goes through the GAHLES portal with a floor plan showing the square footage of every room, and until DBHDD finishes rewriting the ARMHP rules, programs are held to the existing DCH rules in Chapter 111-8-2.

    Crisis Stabilization Units are their own category

    CSUs provide short-term residential care built around psychiatric stabilization and detoxification services, and DBHDD both licenses them and designates them as emergency receiving and evaluating facilities, which is part of how Rule 82-3-1 defines a CSU. The rules governing CSUs make clear that compliance with CSU-specific regulations doesn’t release a facility from other applicable federal, state, or local requirements, and where CSU rules exceed other codes, the CSU rules control.

    Timeline and the Certificate of Need

    An ARMHP isn’t a hospital, and Georgia’s Certificate of Need rules for psychiatric inpatient programs are written around designated beds in licensed hospitals, so a residential program usually skips CON review. A hospital-based psychiatric unit is a different story and goes through DCH. On the licensing side, DBHDD’s packet promises an initial review within 30 business days of submission, and a complete application still typically goes through 1 to 3 rounds of state requests for additional information. An incomplete package commonly adds 3 to 9 months.

    Licensure isn’t a funding guarantee

    Georgia’s CSU regulations state this plainly: licensure doesn’t constitute an entitlement to any type or level of funding. Getting licensed is a necessary step, not a sufficient one, for the financial side of operating a CSU or ARMHP. Funding relationships are a separate conversation entirely from the licensing process itself.

    Ketamine and Spravato in Georgia CSUs and Residential Programs

    An interpretation built from DBHDD’s facility categories, the CSU rules described above and the Spravato REMS. DBHDD hasn’t issued ketamine guidance.

    A Crisis Stabilization Unit already provides psychiatric stabilization with medical and nursing staff on site, which makes it the more natural DBHDD setting for ketamine or Spravato. An Adult Residential Mental Health Program is lower acuity and will need to show DBHDD how it intends to staff and monitor a medical procedure it doesn’t otherwise provide. Either way, adding the service is a scope question for DBHDD to settle before launch. A psychiatric hospital licensed by HFRD adds it through its own medical staff instead.

    In Georgia an ARMHP is the better place to start a series, because residents stay long enough for staff to compare the days before and after several sessions. A CSU admission rarely runs past a week, so a patient who begins ketamine there should come out of the first session already knowing which outpatient prescriber will continue it.

    Spravato’s REMS requires the unit to be certified as a healthcare setting and to watch each patient for two hours after a dose. Because the drug is approved for major depression with acute suicidal ideation, it lines up closely with the population many Georgia CSUs admit.

    Where This Fits In

    This covers DBHDD residential and CSU licensure specifically. See Georgia Behavioral Health Licensing for the full picture.

    This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

    Deciding between a CSU and a residential treatment facility structure in Georgia?

    Sources

  • Georgia Drug and Alcohol Outpatient Licensing: DATEP Requirements

    Georgia Drug and Alcohol Outpatient Licensing: DATEP Requirements

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Apply now: HFRD Application For New Facilities | Questions: Licensure.Application@dbhdd.ga.gov

    Georgia Drug and Alcohol Outpatient Licensing: DATEPs Under New Management

    Outpatient substance use treatment in Georgia is licensed as a Drug Abuse Treatment and Education Program (a DATEP), and as of January 1, 2026, that license moved to a different agency than the one many operators still assume handles it.

    DBHDD, not DCH, licenses DATEPs now

    House Bill 584 transferred DATEP licensing and oversight to the Department of Behavioral Health and Developmental Disabilities, away from the Department of Community Health. This is recent enough that a real amount of third-party guidance (some published in 2026 itself) still describes DATEPs as DCH-regulated. If you’re planning around older information, or even fairly recent professional guidance, verify against DBHDD’s current published requirements rather than assuming continuity with the pre-2026 structure.

    IOP is an outpatient program type, and PHP isn’t a DATEP term

    Georgia’s DATEP rules license program types rather than ASAM level-of-care names. Rule 82-10-1-.24 says substance abuse intensive outpatient programs are licensed as outpatient drug treatment programs, and the rules separately recognize specialized day treatment and ambulatory detoxification. The phrase “partial hospitalization” doesn’t appear in the rules, so a day program has to fit one of the listed types, and the license spells out each type you’re authorized to run.

    What the timeline actually looks like

    Standard outpatient DATEP programs typically run 6 to 10 months from concept to operating certificate. Add PHP or IOP-level programming and that stretches to 8 to 12 months, since the structured-service standards above draw more scrutiny during the state’s document review. Neither of these triggers a Certificate of Need, since Georgia’s CON rules for psychiatric and substance abuse programs are aimed at hospital beds. DBHDD’s application packet promises an initial review within 30 business days of submission, but expect 1 to 3 rounds of requests for additional information even on a well-prepared submission. Incomplete documentation commonly adds another 3 to 9 months on top of the ranges above.

    Know your DBHDD regional field office

    DBHDD has six regional field offices that coordinate services, monitor quality and investigate complaints in their part of the state. They don’t issue licenses, but they’re DBHDD’s local presence, so introducing the program to yours early is worth an afternoon.

    Medication-assisted treatment

    Outpatient programs should maintain a real pathway to medication-assisted treatment. Given that NTP licensure also moved to DBHDD under HB 584, if your outpatient program coordinates with a narcotic treatment program for MAT access, confirm that partner’s current regulatory standing rather than assuming it hasn’t changed.

    Setting Up a Ketamine Clinic Next to a Georgia DATEP

    Drawn from Georgia’s professional corporation and medical practice law and DBHDD’s DATEP structure. Georgia hasn’t written rules for ketamine clinics, so this is a framework to test with counsel.

    A DATEP license covers substance use treatment and education, and a ketamine clinic treating depression is a medical practice, so the two usually run as separate entities. Georgia law doesn’t prohibit the clinic. If the build-out involves significant capital spending, confirm with DCH whether any Certificate of Need threshold applies before you sign contracts.

    Ownership

    We didn’t find a Georgia statute or Composite Medical Board rule that says who may own a ketamine clinic, so the ownership structure belongs with health care counsel. Plenty of operators still choose a physician-owned professional corporation or LLC, and in that setup a lay investor’s stake goes in an MSO that leases space and runs administration for a fixed, fair-market fee, while the physician entity holds the DEA registration and every clinical decision. The physicians at the center of that structure are licensed by the Georgia Composite Medical Board.

    Working Beside the DATEP

    If the clinic shares a building with the DATEP, it’s worth telling the DBHDD regional field office, since the program now has a medical neighbor. Keep records separate, keep ketamine under the clinic’s own DEA registration in a cabinet counseling staff can’t open, and get 42 CFR Part 2 consent before a client’s addiction treatment information moves to the clinic. Nurse practitioners in the clinic work under a protocol agreement with a delegating physician, filed with the Composite Medical Board, and Board Rule 360-32-.02 requires it to name the drugs and treatments they’re delegated, so ketamine and its monitoring standard belong in that document.

    How to Submit Your DATEP Application

    DATEP applications are still submitted through the HFRD online application portal during this transition period, with completed forms and payments forwarded to DBHDD automatically. For general application questions specifically, DBHDD’s contact is Licensure.Application@dbhdd.ga.gov.

    Where This Fits In

    This covers DATEP outpatient licensing specifically. See Georgia Behavioral Health Licensing for the full picture.

    This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

    Confirming your DATEP’s standing under DBHDD’s current oversight?

    Sources

  • Georgia Drug and Alcohol Inpatient Licensing: The HB 584 Transition

    Georgia Drug and Alcohol Inpatient Licensing: The HB 584 Transition

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Apply now: GAHLES Application For New Facilities (a DCH system that forwards DATEP filings to DBHDD) | Questions: Licensure.Application@dbhdd.ga.gov or (404) 657-2252

    Correction (October 2026): an earlier version of this guide said HFRD still licenses detox and residential substance use programs and that Georgia requires a pre-application orientation and a Certificate of Need for residential programs. Under HB 584 and DBHDD’s DATEP rules, residential detox and residential treatment programs are DATEPs licensed by DBHDD, we found no orientation requirement in either agency’s application packet, and Georgia’s CON rules for psychiatric and substance abuse beds apply to hospital programs. The guide has been updated.

    Georgia Drug and Alcohol Inpatient Licensing: A Regulator Change You Need to Know About

    Georgia moved the regulatory goalposts on several facility types at the start of this year, and plenty of prior research hasn’t caught up. If the last time you looked into Georgia licensing was before this year, some of what you knew just changed. Georgia House Bill 584, effective January 1, 2026, transferred licensing and oversight of several facility types, including Drug Abuse Treatment and Education Programs (DATEPs) and Narcotic Treatment Programs (NTPs), from the Department of Community Health to the Department of Behavioral Health and Developmental Disabilities. Even some professional guidance published earlier this year still describes the old structure, so don’t assume older sources, or your own prior research, reflect where things actually stand.

    Who licenses what, right now

    DBHDD now oversees licensure for DATEPs and NTPs, alongside Adult Residential Mental Health Programs and Community Living Arrangements. That includes residential care. DBHDD’s DATEP rules (Ga. Comp. R. & Regs. 82-10-1) treat a residential sub-acute detoxification program, a residential intensive treatment program and a residential transitional treatment program as DATEP program types, so a free-standing detox or residential rehab now gets its license from DBHDD. The Department of Community Health’s Healthcare Facility Regulation Division (HFRD) still licenses hospitals, including hospital-based psychiatric and substance use units. During this transition period, you may still be routed through DCH’s application systems even for a DBHDD-overseen facility type; DCH forwards those completed forms and payments to DBHDD automatically, so don’t assume a DCH-branded form means DCH is your actual regulator.

    Those DATEP program types carry Georgia’s own names rather than ASAM’s numbered residential levels. For a residential intensive treatment program that wants outside confirmation of the level it runs at, CARF’s ASAM Level of Care Certification is available for adult Levels 3.1, 3.5 and 3.7. A referral source won’t necessarily find it on the DBHDD license, but they can pull it up in CARF’s provider search.

    What the DATEP rules ask of a detox program

    A residential sub-acute detox program needs a medical director licensed to practice medicine in Georgia, a registered nurse designated as director of nursing, physician or physician extender coverage on call 24 hours a day, and one RN or LPN awake and on duty on the premises around the clock (Rule 82-10-1-.19). A residential intensive treatment program without detox has a lighter medical requirement: a written agreement with a physician or physician extender for medical care. DBHDD surveys the program against those rules. Three things come up repeatedly during surveys because they go directly to patient safety: whether staff credentials were actually verified against the primary source, meaning the licensing or certifying body itself, rather than just a copy of a card on file, whether any staff member is practicing outside what their specific license or certification actually permits, and whether evidence-based risk assessments like the Columbia-Suicide Severity Rating Scale are being completed and signed off by clinical staff, not left as a form filled in without genuine clinical review.

    Certificate of Need is mostly a hospital question

    Georgia’s Certificate of Need planning rules for psychiatric and substance abuse inpatient programs are written around designated beds inside a licensed hospital. A free-standing residential DATEP isn’t one of those, so most residential programs never go through CON review. A hospital-based unit does, and a large capital project can raise its own CON question, so a short call to DCH’s Office of Health Planning before you commit to a site is cheap insurance.

    What goes in the application

    DBHDD’s DATEP application packet asks for city or county zoning approval, a floor plan showing the square footage of every room, and a state fire marshal inspection report dated within 12 months of submission. Application fees are non-refundable. The packet commits to an initial review within 30 business days of submission, so most of the calendar goes to the lease, the build-out, the fire marshal and hiring, and an incomplete package commonly adds 3 to 9 months of back-and-forth.

    Medication-assisted treatment

    Methadone access runs through a Narcotic Treatment Program, its own license category, not something folded into a residential DATEP license. A residential facility without that license needs an actual partnership with a separately licensed OTP or MOUD provider to get clients access to methadone, the same structural arrangement operators in California handle through networks like BAART. Georgia has its own real equivalents. New Season operates several SAMHSA-certified opioid treatment programs across the state, including locations in Augusta, Columbus, and Savannah, and naming the specific provider a program actually coordinates with is a stronger answer to this question than describing the arrangement in the abstract. Buprenorphine and naltrexone are more flexible: any practitioner whose DEA registration covers Schedule III can prescribe buprenorphine since the federal waiver requirement ended in 2023, and naltrexone needs only ordinary prescribing privileges. Given that NTP licensure itself just moved to DBHDD under HB 584, confirming your MAT coordination partner’s current regulatory status is worth double-checking right now, not assuming it’s unchanged.

    Ketamine in a Georgia Residential or Detox Program

    Pulled together from Georgia’s drug abuse treatment program rules and its professional ownership law. Neither mentions ketamine, so read this as an interpretation and get DBHDD’s answer for a specific program.

    Georgia’s program rules already put a licensed physician in charge of every client’s medical care, and they limit medication administration to physicians, physician assistants and nurses, with everything kept under lock and key between doses. A ketamine protocol fits inside that structure. What it can’t do is appear quietly. The license describes each type of service and program the licensee is authorized to provide, any change has to be reported, and the department decides whether the change needs a new license. A psychiatric treatment layered onto a detox or residential license is exactly that kind of change, and it should go to DBHDD before the first patient, since detox and residential DATEP licensing moved there under HB 584.

    No Georgia Board of Nursing position on psychiatric ketamine turned up in the research for this page, so the facility’s own protocol carries the detail: sub-anesthetic dosing, continuous monitoring, who adjusts the infusion and who must stay in the building. Georgia nurse practitioners can be delegated Schedule III through V prescribing under a protocol agreement with a physician, filed with the Composite Medical Board, and Rule 360-32-.02 says that agreement has to spell out the drugs and treatments the NP may order, so ketamine needs to be written into it by name.

    Choosing Residents Carefully

    Detox and the first days of residential care are poor moments to start ketamine for most people. A resident still in withdrawal can’t give a reliable picture of mood, and anyone whose history includes ketamine or other dissociatives is a candidate for something else. The stronger case is a resident some weeks into treatment whose depression or PTSD has held on through adequate medication trials.

    Continuing After Discharge

    Starting the series in residential care lets staff watch the days between sessions, not only the hour in the chair. A resident who responds well can continue at an outpatient ketamine clinic, and we didn’t find a Georgia statute or Composite Medical Board rule that spells out who may own that clinic, so ownership is a question for health care counsel. A common setup is a physician-owned professional corporation or LLC with a management services organization running the business side for a fair-market-value fee, and whatever structure you choose has to operate the way the paperwork describes. More on that clinic is in the ketamine section of Georgia Drug and Alcohol Outpatient Licensing: DATEP Requirements. A residential program sending residents to an affiliated clinic raises federal Eliminating Kickbacks in Recovery Act (18 U.S.C. § 220) questions whoever pays, so get counsel’s review before referrals begin.

    Staffing a residential program

    Georgia’s clinical intern pipeline is the real lever on residential and detox staffing costs. Georgia’s addiction counselors run $40,000 to $60,000 annually statewide, with Atlanta-area pay closer to $62,000 to $64,000. Detox costs meaningfully more than outpatient, since the DATEP rules require an RN or LPN awake on site around the clock and 24-hour physician on-call coverage on top of counseling staff, with nursing coverage alone commonly adding $150,000 to $250,000 a year depending on shift coverage. Those figures look steep in isolation, and most Georgia operators never actually pay them in full. A clinical director supervising several clinical interns working toward their CADC-T or CADC-I hours, at reduced wages in exchange for the supervised experience their credential requires, can cut clinical staffing costs by 40 to 60% compared to a fully credentialed roster. On the nursing side, most programs can run with one RN as director of nursing overseeing several LPNs rather than an all-RN team. The actual staffing matrix, mitigation strategies included, comes together once program model and applicable agency are confirmed.

    How to Submit Your DATEP Application

    Residential and detox DATEP applications go in through the GAHLES Application For New Facilities portal, which DCH still runs during the transition and which forwards completed forms and payments to DBHDD. For application questions, DBHDD’s contact is Licensure.Application@dbhdd.ga.gov or (404) 657-2252.

    Frequently Asked Questions

    Does a DCH-branded application form mean DCH is my actual regulator?

    Not necessarily. During this transition period, some facility types now overseen by DBHDD may still route through DCH’s application systems, which forward completed forms and payments to DBHDD automatically. Confirm your actual regulator against current agency assignments rather than the form’s letterhead.

    Does a residential rehab in Georgia need a Certificate of Need?

    Usually not. Georgia’s CON rules for psychiatric and substance abuse inpatient programs cover beds in licensed hospitals, and a free-standing residential DATEP isn’t a hospital. Where CON does apply, it’s a separate DCH review, not part of the DBHDD license application.

    Can one DATEP license cover both detox and residential treatment?

    The license lists each program type the provider is authorized to run, and residential sub-acute detox and residential intensive treatment are separate program types under the rules. Put every type you plan to offer on the application.

    See our Georgia Behavioral Health Licensing page for the full picture.

    This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

    Sorting out DBHDD versus HFRD for a Georgia residential program? Let’s talk it through.

    Sources

  • Pennsylvania License Reinstatement: DDAP and OMHSAS Appeal Paths

    Pennsylvania License Reinstatement: DDAP and OMHSAS Appeal Paths

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Pennsylvania License Reinstatement: Two Different Appeal Paths

    Pennsylvania’s enforcement process gives providers real due process, but which path you’re on, and how much time you have to respond, depends on whether DDAP or OMHSAS is the agency involved.

    DDAP: deficiencies, show cause, and a 30-day clock

    Under Chapter 709, if a facility doesn’t correct cited deficiencies within the specified time, DDAP issues a formal notice that the licensee must show cause why its license shouldn’t be revoked. From the date that show cause order is received, the facility has 30 days to file a written request for a hearing. That’s a hard deadline, and the hearing itself proceeds under Pennsylvania’s General Rules of Administrative Practice and Procedure, a real, formal administrative process, not an informal conversation with a field inspector.

    OMHSAS: a different bureau handles the appeal

    Mental health facility license sanctions and revocations against a DHS-licensed provider go through the Department of Human Services’ Bureau of Hearings and Appeals (BHA) instead, a completely different appellate body from the one handling DDAP matters. Because a licensing appeal isn’t a benefits case, DHS routes it through the general administrative rules in 1 Pa. Code Chapters 31, 33 and 35, while Chapter 275 of Title 55 is written for people applying for or receiving assistance. DHS’s hearings page spells out that split, and 55 Pa. Code § 20.82 lines up with it: a legal entity appeals the denial, nonrenewal or revocation of its certificate of compliance under 1 Pa. Code Part II, by petition filed within 30 days after service of the notice. The sanction notice itself should say where that petition goes, so read it closely before the clock gets short. BHA’s docket runs from Medical Assistance provider enrollment disputes to licensure sanctions.

    Correction (October 2026): An earlier version of this page said BHA hears provider licensing appeals under 55 Pa. Code Chapter 275. DHS states that non-recipient appeals, which include licensing actions, are heard under 1 Pa. Code Chapters 31, 33 and 35. Chapter 275 governs recipient appeals.

    Full or provisional licensure changes what’s at stake

    DDAP’s Chapter 709 has two license types. A full license issues once an inspection shows the facility meets the chapter. A provisional license (§ 709.13) lasts no more than 6 months, can be renewed no more than three times, and depends on the facility following an approved course of correction. A facility already on provisional status is in a weaker position going into a deficiency dispute, because failing to follow an approved plan of correction is itself a ground for revocation under § 709.17. Separately, § 709.14 ties every license to its named owner, premises and activities, and an unreported change in any of them (90 days is the limit) makes the license expire automatically. Know which status you’re actually defending before you decide how to respond.

    What actually helps in either process

    Whether you’re facing a DDAP show-cause hearing or an OMHSAS matter before BHA, documented and verifiable corrective action, implemented and confirmed, not simply promised, carries real weight in a formal administrative proceeding. Facilities that can demonstrate precisely what was wrong and how it’s been genuinely fixed are in a fundamentally stronger position than those offering general assurances.

    Where This Fits In

    This covers DDAP and OMHSAS enforcement and reinstatement specifically. See Pennsylvania Behavioral Health Licensing for the full picture.

    This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

    Facing a DDAP or OMHSAS enforcement action in Pennsylvania?

    Sources

  • Pennsylvania Mental Health Outpatient Licensing: Chapters 5200 and 5210

    Pennsylvania Mental Health Outpatient Licensing: Chapters 5200 and 5210

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Pennsylvania Mental Health Outpatient Licensing: Chapters 5200 and 5210

    Outpatient mental health care in Pennsylvania splits by intensity, with OMHSAS licensing psychiatric outpatient clinics and partial hospitalization programs under two separate chapters that share underlying structure but different standards.

    Psychiatric outpatient clinics: Chapter 5200

    Standard outpatient mental health treatment is licensed under Chapter 5200, which requires a written plan on file specifying the clinic’s clinical policy and procedures, a qualified director or clinical supervisor, defined staffing patterns that distinguish advanced practice professionals from volunteers, psychiatric supervision requirements, and criminal history checks for staff and volunteers with direct contact, plus child abuse certification when the clinic serves children (§ 5200.24). Every one of these is a specific, checkable requirement rather than general guidance a clinic can approximate.

    Partial hospitalization: Chapter 5210

    A more intensive outpatient level of care, partial hospitalization, is licensed separately under Chapter 5210. Don’t assume a Chapter 5200 outpatient clinic license automatically extends to cover partial hospitalization programming. If your clinic is building toward that intensity, confirm you’re actually authorized under 5210 before you start delivering it.

    Waivers exist, but they follow a real process

    Chapter 5200 allows a facility to request a waiver from specific standards where the regulations severely limit specialty service development, and rural clinics or specialty programs are the examples the regulation itself gives. The regulation itself, § 5200.48, says only that waivers are for exceptional circumstances, need documented attempts to meet the standards and are subject to Department approval. The working steps (county MH/IDD review, routing to the OMHSAS field office, renewal lead times and appeal rights) come from OMHSAS Bulletin OMHSAS-24-04, which we couldn’t re-check for this update, so pull the current bulletin before you file anything.

    Layered building and safety codes still apply

    Chapter 5200 explicitly doesn’t replace other applicable regulations, so 34 Pa. Code’s building and fire safety provisions still apply on top of the mental health-specific standards, alongside the confidentiality and patient rights provisions in Chapter 5100. A compliance file built around Chapter 5200 alone, without accounting for these layered requirements, is missing real pieces.

    Ketamine in a Chapter 5200 Clinic or 5210 Partial Program

    An interpretation of 55 Pa. Code Chapters 5200 and 5210 and OMHSAS’s licensing practice. Pennsylvania’s Board of Nursing hasn’t published ketamine guidance.

    A Pennsylvania psychiatric outpatient clinic is a medically supervised setting by definition. Section 5200.3 says its services are provided under medical supervision, § 5200.22 requires two hours of psychiatric time each week for every full-time clinical position, at least half of it on site, and § 5200.31 names medication evaluation and management among the services an individual treatment program can include. Adding ketamine or Spravato extends something the license already contemplates rather than bolting on something foreign.

    The notice rule is short. Section 5200.11(d) requires the clinic to notify the Department within 10 days of a major change in its organizational structure or services, and § 5200.11(c) requires a written description of the clinic’s programs to be available to the Department, so update that description when ketamine is added. A partial hospitalization program under Chapter 5210 reports major service changes to the Department under § 5210.11 and runs on two psychiatric hours per week for every five patients of capacity, which affects how many infusion days a psychiatrist can actually cover.

    Ownership needs a look too. Pennsylvania’s corporate practice limits come from case law rather than a statute, so if the clinic isn’t physician-owned, have counsel review how the psychiatrist who orders ketamine is engaged. A nurse practitioner who orders or monitors sessions needs a collaborative agreement that names ketamine.

    Where This Fits In

    This covers outpatient mental health licensure under Chapters 5200 and 5210 specifically. See Pennsylvania Behavioral Health Licensing for the full picture.

    This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

    Determining whether your Pennsylvania program needs Chapter 5200 or 5210 licensure?

    Sources

  • Pennsylvania Mental Health Inpatient Licensing: OMHSAS Requirements

    Pennsylvania Mental Health Inpatient Licensing: OMHSAS Requirements

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Pennsylvania Mental Health Inpatient Licensing: OMHSAS and the 5100 Series

    Inpatient mental health care in Pennsylvania is a completely separate regulatory world from DDAP’s drug and alcohol licensing: different department, different chapters, different oversight structure entirely.

    OMHSAS, not DDAP, is your regulator

    The Office of Mental Health and Substance Abuse Services licenses mental health facilities under program-specific chapters in Title 55 of the Pennsylvania Code. Chapter 5100 (Mental Health Procedures) sits alongside them. It isn’t a licensing chapter; it carries out the Mental Health Procedures Act, covering voluntary and involuntary treatment, confidentiality of records and patient rights. Private psychiatric hospitals fall under Chapter 5300 specifically. A psychiatric unit inside a general acute-care hospital needs facility approval under § 5100.12, which the Department of Human Services grants through its Deputy Secretary of Mental Health and renews every year on application. Ask OMHSAS early what that approval will involve on top of the hospital’s own Department of Health licensing.

    Residential mental health has its own separate tiers

    Community Residential Rehabilitation Services for people with mental illness are licensed under Chapter 5310, and Long-Term Structured Residences fall under Chapter 5320, both separate from the acute inpatient hospital track. If your program is residential but not hospital-level, confirm whether Chapter 5310 or 5320 actually describes what you’re building rather than assuming Chapter 5300’s hospital standards apply.

    Adequate treatment has a real definition here

    Chapter 5100 also defines what counts as adequate treatment (§ 5100.11): individually designed care reflecting the person’s needs both independently and in light of available community, family, and friend support, delivered at the least restrictive setting appropriate. Involuntary treatment, any voluntary inpatient treatment, and voluntary outpatient treatment paid for at least partly with public money aren’t considered adequate unless delivered at an approved facility (or by a federal agency). That’s a real compliance standard, not just aspirational language.

    Ketamine and Spravato Under OMHSAS Licensing

    An interpretation applying the OMHSAS chapters described above to ketamine and the Spravato REMS. OMHSAS hasn’t issued ketamine guidance.

    A private psychiatric hospital under Chapter 5300, or an OMHSAS-approved psychiatric unit in a general hospital, already runs with psychiatrists and psychiatric nursing on staff, so adding ketamine or Spravato is mostly a medical staff and pharmacy decision. Residential programs are a different matter. A Community Residential Rehabilitation Service under Chapter 5310 or a Long-Term Structured Residence under Chapter 5320 is licensed for a residential model, and either should ask its OMHSAS licensing contact whether a medical procedure like an infusion fits its license before planning on it. Chapter 5100’s definition of adequate treatment, individually designed and delivered in the least restrictive appropriate setting, is the standard a ketamine order should be documented against.

    Pennsylvania hospital stays are short, but even a week or two gives the treatment team a few sessions of observation that an outpatient practice would need a month to gather. That helps the patient and whoever continues care afterward, so the discharge plan should name that prescriber when the first order is written. Spravato adds an FDA REMS enrollment for the unit and a required observation window after each dose, and an inpatient schedule absorbs that wait without trouble. Check the current REMS terms for the exact period.

    Where This Fits In

    This covers OMHSAS inpatient and residential mental health licensure specifically. See Pennsylvania Behavioral Health Licensing for the full picture.

    This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

    Figuring out which OMHSAS chapter governs your Pennsylvania program?

    Sources

  • Pennsylvania Drug and Alcohol Outpatient Licensing: DDAP Requirements

    Pennsylvania Drug and Alcohol Outpatient Licensing: DDAP Requirements

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Apply now: Request for Licensing Application Packet Form | Questions: ra-licensuredivision@pa.gov

    Pennsylvania Drug and Alcohol Outpatient Licensing: The Same Chapter, Different Standards Inside It

    Outpatient SUD treatment in Pennsylvania sits under the same Chapter 709 framework as residential care, with the same DDAP oversight, but the standards that actually apply to your program depend heavily on the specific service you’re licensed to deliver.

    Staffing and physical plant standards still apply

    Chapter 704’s staffing requirements and Chapter 705’s physical plant standards apply to outpatient programs the same way they apply to residential ones, so an outpatient license doesn’t mean a lighter compliance file, just a different physical footprint. DDAP reviews both as part of licensure, and having them squared away before you submit is what actually shortens your real-world timeline, not the pace of DDAP’s own review.

    Narcotic treatment needs a separate approval on top of the license

    If your outpatient program includes methadone or another narcotic-based medication treatment, Chapter 715 applies. It isn’t a separate license. It’s an approval that sits on top of your DDAP facility license, and the program also needs a DEA registration and SAMHSA certification before it opens its doors to patients. A program can hold a general Chapter 709 outpatient license and still need Chapter 715 approval if it adds narcotic treatment services later. One doesn’t automatically extend to cover the other.

    The annual inspection cycle applies here too

    Outpatient Chapter 709 licenses run on the same one-year cycle as residential licenses, with DDAP scheduling an annual on-site inspection ahead of renewal. Treating outpatient licensure as a lighter, less frequently reviewed category than residential care is a mistake, because the review cadence is identical.

    Medication-assisted treatment

    Outpatient programs should maintain a real pathway to medication-assisted treatment, whether or not they hold Chapter 715 narcotic treatment authorization directly. A working relationship with a buprenorphine or naltrexone prescriber, or a genuine coordination arrangement with a licensed narcotic treatment program, matters more to both clients and DDAP than a referral list that goes cold.

    A Ketamine Clinic Next to a Pennsylvania Outpatient Program

    Based on Pennsylvania case law on corporate practice, DDAP’s activity licensing and the state’s nurse practitioner rules. Pennsylvania has no ketamine clinic rules, so treat this as a framework for counsel.

    Pennsylvania doesn’t prohibit stand-alone ketamine clinics. DDAP licenses drug and alcohol activities, so a clinic treating depression with ketamine sits outside DDAP’s licensing and usually runs as a separate medical practice beside the outpatient program.

    Structuring the Practice

    The ownership rule here is judge-made. Pennsylvania courts limit ownership of a medical practice to licensed professionals, and the management agreements that draw the most scrutiny are the ones with long terms, MSO control over clinical matters, or a split of profits that starts to look like a partnership. A management agreement for a ketamine clinic should run on a shorter renewable term, leave every clinical call with the physicians and pay the MSO a fixed fee rather than a cut of revenue. The clinic itself is typically a physician-owned professional corporation or, when organized as an LLC, a restricted professional company, which is the form the Pennsylvania Department of State requires for an LLC rendering medicine and surgery.

    Running It Next to a DDAP Program

    Keep the clinic’s records, schedules and ketamine supply separate from the licensed outpatient activity, with ketamine under the clinic’s own DEA registration, and get written consent under 42 CFR Part 2 before a client’s addiction treatment record goes to the clinic. If the outpatient provider instead tries to bring ketamine under its DDAP license, the 90-day change-in-activity report under 28 Pa. Code § 709.14 comes into play, an unreported change makes the license expire automatically, and DDAP should be asked whether the addition needs a new application on top of that report. Nurse practitioners in the clinic work under collaborative agreements with physicians that should name ketamine explicitly.

    How to Submit Your DDAP Application

    Outpatient programs use the same Request for Licensing Application Packet Form as residential facilities, selecting outpatient as the proposed activity. Email it to ra-licensureapps@pa.gov. For general questions, DDAP’s Division of Licensing Operations can be reached at ra-licensuredivision@pa.gov.

    Where This Fits In

    This covers outpatient licensing under Chapter 709 specifically. See Pennsylvania Behavioral Health Licensing for the full picture.

    This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

    Determining whether your Pennsylvania program needs Chapter 715 narcotic treatment approval too?

    Sources

  • Pennsylvania Drug and Alcohol Inpatient Licensing: Chapter 709 Requirements

    Pennsylvania Drug and Alcohol Inpatient Licensing: Chapter 709 Requirements

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Apply now: Request for Licensing Application Packet Form | Questions: ra-licensuredivision@pa.gov

    Pennsylvania Drug and Alcohol Inpatient Licensing: Chapter 709 Requirements

    Residential substance use treatment in Pennsylvania runs through DDAP’s Chapter 709 (Standards for Licensure of Freestanding Treatment Facilities), and the internal structure of that chapter matters as much as the fact that it exists.

    Your license expires every year, on purpose

    A DDAP license under Chapter 709 is valid for one year from issuance, not longer. Before it expires, DDAP notifies the facility of the date for an annual on-site inspection tied to renewal, so this isn’t a passive renewal you can let happen on paperwork alone. Every year, your facility goes back through a real inspection.

    Full and provisional licenses aren’t the same status

    Chapter 709 has two kinds of license. A full license (§ 709.12) issues after an on-site inspection finds the facility meets the chapter. A provisional license (§ 709.13) covers a facility that has substantially but not completely complied, is following an approved course of correction, and has no deficiencies that endanger clients. It lasts no more than 6 months and can be renewed no more than three times, so a facility can’t sit on provisional status indefinitely. Section 709.14, titled “Restriction on license,” isn’t a third status. It says the license belongs to the named person, facility, premises and activities, can’t be transferred, and requires you to report changes in ownership, name, location, activity, capacity or closure within 90 days.

    Recovery houses live in a different chapter entirely

    Recovery house licensing comes from its own article of The Administrative Code of 1929 (71 P.S. §§ 613.11 to 613.18), and DDAP wrote its standards as a separate Chapter 717 (Standards for Drug and Alcohol Recovery House Licensure) rather than folding them into Chapter 709. If you’re running a recovery house alongside a treatment program, don’t assume 709’s standards apply to the recovery house piece. They don’t. Whether a particular house has to be licensed turns on the statute’s funding and referral triggers, which we couldn’t re-check for this update, so confirm your house’s status with DDAP before you assume a private-pay model keeps you outside Chapter 717.

    ASAM level certification through CARF

    If you want a residential program’s ASAM level confirmed by an outside body, CARF offers a separate route. Its ASAM Level of Care Certification, run in partnership with ASAM, covers adult residential Levels 3.1, 3.5 and 3.7. Your Chapter 709 license may say nothing about it. A payer who wants to check runs the level through the certification filter in CARF’s provider search.

    Medication-assisted treatment

    Methadone treatment runs through Chapter 715, which is an approval layered on top of a DDAP facility license, not a license of its own. A narcotic treatment program needs the DDAP license, DDAP’s Chapter 715 approval, a DEA registration and SAMHSA certification before it can operate. A residential facility without that approval needs an actual coordination relationship with an approved narcotic treatment program for any resident who needs it, named specifically rather than described in the abstract. Documenting the specific program you coordinate with is the kind of clinical capability DDAP expects to see on paper, not just claimed in a policy manual. Buprenorphine and naltrexone are more flexible: any practitioner whose DEA registration covers Schedule III can prescribe buprenorphine since the federal waiver requirement ended in 2023, and naltrexone needs only ordinary prescribing privileges.

    Ketamine in a Chapter 709 Residential Program

    Drawn from DDAP’s licensing structure and change-reporting rules, plus Pennsylvania’s case law on corporate practice. Neither DDAP nor the State Board of Nursing has addressed psychiatric ketamine directly, so this is an interpretation to confirm with DDAP before launch.

    DDAP licenses facilities by drug and alcohol activity, and ketamine for depression isn’t one of them. That makes it a medical service delivered by the facility’s prescribers inside a licensed setting, not a line item DDAP approves on its own. It still touches the license. DDAP requires a facility to report a change in activity within 90 days, and failing to report a listed change triggers automatic expiration of the license. Whether a brand-new activity can be handled by that notice or needs a fresh application packet isn’t spelled out in § 709.14, so ask DDAP’s Division of Licensing Operations which path a ketamine protocol falls under before the first dose, since the annual Chapter 709 inspection will see it either way.

    No Pennsylvania State Board of Nursing guidance specific to psychiatric ketamine turned up in research for this page, so the facility’s own protocol carries the dosing limits, monitoring and on-site coverage. Pennsylvania nurse practitioners prescribe under a collaborative agreement with physicians, and that agreement should name ketamine if an NP will order it.

    Who Belongs in the Chair

    In a Chapter 709 program, ketamine makes sense for a resident whose withdrawal is behind them and whose depression or PTSD has shrugged off ordinary medication. A resident who has used ketamine or other dissociatives recreationally shouldn’t get it. Ketamine also isn’t a Chapter 715 narcotic treatment medication or an addiction medication of any kind, so it doesn’t replace the methadone coordination relationship described above.

    After Discharge

    Watching a resident through the days between early sessions is the part of a 709 stay no clinic can reproduce, and when a resident responds, the next stop after discharge is usually an outpatient ketamine clinic. Pennsylvania’s corporate practice of medicine rule comes from case law rather than a statute, and management agreements that split profits with a non-physician company draw the most scrutiny. A physician-owned professional corporation paired with an MSO paid a fixed, fair-market fee is the usual answer. The details are in the ketamine section of Pennsylvania Drug and Alcohol Outpatient Licensing: DDAP Requirements. Referrals from a residential program into an affiliated clinic also need counsel’s review under the federal Eliminating Kickbacks in Recovery Act (18 U.S.C. § 220).

    Staffing a residential program

    How you mix credentialed and still-certifying counselors under one supervisor is the real lever operators have on residential staffing costs. Pennsylvania addiction counselors earn a median of $58,320 a year, close to the national median. A residential Chapter 709 program with a program director and several CADC-credentialed counselors commonly runs $250,000 to $330,000 a year in clinical payroll, with Chapter 704’s more intensive staffing requirements pushing residential and detox costs above what a comparable outpatient program would run. Those figures look steep in isolation, and most Pennsylvania operators never actually pay them in full. A clinical director supervising several counselors who are still logging the work experience and supervision hours certification requires (the CAAC alone takes years of supervised full-time work, so check the Pennsylvania Certification Board’s current hour counts), at lower wages than certified staff, can cut clinical staffing costs by 40 to 60% compared to an all-CADC roster. On the nursing side, most residential programs can run with one RN overseeing several LPNs rather than an all-RN team. Once your program model is confirmed, the actual staffing matrix and cost estimate follow, mitigation strategies included.

    How to Submit Your DDAP Application

    Start with the Request for Licensing Application Packet Form, selecting the drug and alcohol activities your facility will provide, and email it to ra-licensureapps@pa.gov. For general questions, DDAP’s Division of Licensing Operations can be reached at ra-licensuredivision@pa.gov.

    Frequently Asked Questions

    Is a provisional DDAP license the same as full licensure?

    No. A provisional license under § 709.13 is issued for no more than 6 months to a facility that is close to compliance and working through an approved correction plan, and it can be renewed no more than three times. A full license issues only once an inspection shows the facility meets Chapter 709.

    Does operating a recovery house require DDAP licensure under Chapter 709?

    No. Recovery houses fall under Chapter 717, a separate chapter from treatment facilities, written under 71 P.S. §§ 613.11 to 613.18. Which houses must hold that license depends on the statute’s funding and referral rules, so check with DDAP before relying on a private-pay exemption.

    Does my DDAP license ever stop requiring annual inspection?

    No. A Chapter 709 license is valid for one year from issuance, and DDAP notifies the facility ahead of an on-site inspection tied to every renewal. There’s no point at which this becomes a paperwork-only renewal.

    See our Pennsylvania Behavioral Health Licensing page for the full picture.

    This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

    Sorting out your license status under Chapter 709? Let’s talk it through.

    Sources

  • Arizona License Reinstatement

    Arizona License Reinstatement

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

    Arizona’s enforcement structure gives the Arizona Department of Health Services (ADHS) more flexibility than a simple pass-or-fail approach, and understanding that flexibility matters for how you respond to a finding.

    Correction (October 2026): A.R.S. § 36-424(B) is discretionary (“may”), and it excludes facilities with a § 36-427 or § 36-431.01 enforcement action in the prior year. The accreditation passages below were updated to say so.

    Suspension Can Be Partial, Not All-or-Nothing

    Under A.R.S. § 36-427, ADHS’s director can suspend or revoke a health care institution’s license in whole or in part. That distinction matters in practice. A facility running multiple scopes of service, say both BHRF and Outpatient Treatment Center authorizations, could face action against one scope without automatically losing the other. This connects directly back to how Arizona structures licensing in the first place. Since scope of service defines what you’re actually authorized to do, enforcement can target that scope specifically rather than the license as a whole.

    Formal Proceedings, Not Informal Resolution

    Suspension and revocation proceedings run through Title 41, Chapter 6, Article 10, Arizona’s Administrative Procedure Act. That means a real formal hearing process, not an informal conversation with a field inspector. Facilities disputing an action should expect the same procedural rigor and documentation standards that govern any other contested state administrative action.

    What Accreditation Doesn’t Erase

    Even a facility with deemed-status-style accreditation under A.R.S. § 36-424(B), where ADHS may accept accreditation in lieu of compliance inspections, isn’t protected from enforcement action triggered by a complaint or reasonable cause investigation under § 36-424(C). The same statute also takes the accreditation option off the table for a year: a facility that faced a § 36-427 action, or a civil penalty under § 36-431.01, in the year before its annual licensing fee anniversary date can’t substitute its accreditation report for inspection. If you receive a finding despite holding current accreditation, coordinate your response with your accrediting body as well as ADHS, since a serious state finding can affect your standing with both at once.

    What Actually Holds Up in That Kind of Proceeding

    Given how formal this process is, and given that ADHS can act against a specific scope of service rather than your whole license, documented and verifiable corrective action tied specifically to the scope in question tends to carry more weight than a broad, general response addressing your whole operation. Facilities that can show precisely what was wrong, what was fixed, and how the fix is being sustained for the specific scope at issue are in a fundamentally stronger position than those offering general reassurances.

    Frequently Asked Questions

    Can Arizona suspend part of a license without shutting down the whole facility?

    Yes. Under A.R.S. Section 36-427, ADHS’s director can act against a license in whole or in part, meaning a facility with multiple scopes of service could lose authorization for one scope while continuing to operate under another.

    What kind of hearing process applies to an Arizona license suspension?

    Suspension and revocation proceedings run through Title 41, Chapter 6, Article 10, Arizona’s Administrative Procedure Act, a formal hearing process with real procedural rigor rather than an informal resolution.

    Does holding accreditation protect an Arizona facility from enforcement action?

    Not entirely. Under A.R.S. Section 36-424(B), ADHS may accept accreditation in place of compliance inspections, but not for a facility that had an enforcement action under Section 36-427 or 36-431.01 in the prior year, and ADHS retains authority under Section 36-424(C) to investigate directly on a complaint or reasonable cause basis, regardless of accreditation status.

    Facing a suspension, revocation, or reinstatement question for an Arizona facility? Reach out here.

    Sources

Top